166 related articles for article (PubMed ID: 34788361)
1. Antithymocyte globulin exposure in CD34+ T-cell-depleted allogeneic hematopoietic cell transplantation.
Lakkaraja M; Scordo M; Mauguen A; Cho C; Devlin S; Ruiz JD; Klein E; Avecilla ST; Boulad F; Cancio MI; Curran KJ; Jakubowski AA; Kernan NA; Kung AL; O'Reilly RJ; Papadopoulos EB; Prockop S; van Roessel I; Scaradavou A; Shaffer BC; Shah G; Spitzer B; Tamari R; Giralt SA; Perales MA; Boelens JJ
Blood Adv; 2022 Feb; 6(3):1054-1063. PubMed ID: 34788361
[TBL] [Abstract][Full Text] [Related]
2. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.
Lakkaraja M; Mauguen A; Boulad F; Cancio MI; Curran KJ; Harris AC; Kernan NA; Klein E; Kung AL; Oved J; Prockop S; Scaradavou A; Spitzer B; O'Reilly RJ; Boelens JJ
Cytotherapy; 2024 Apr; 26(4):351-359. PubMed ID: 38349310
[TBL] [Abstract][Full Text] [Related]
3. Individualized rabbit anti-thymocyte globulin dosing in adult haploidentical hematopoietic cell transplantation with high-risk hematologic malignancy: Exposure-response analysis and population pharmacokinetics simulations.
Teramoto M; Takahashi T; Matsumoto K; Jaber M; Kaida K; Tamaki H; Ikegame K; Yoshihara S
Am J Hematol; 2024 Mar; 99(3):387-395. PubMed ID: 38165019
[TBL] [Abstract][Full Text] [Related]
4. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis.
Admiraal R; van Kesteren C; Jol-van der Zijde CM; Lankester AC; Bierings MB; Egberts TC; van Tol MJ; Knibbe CA; Bredius RG; Boelens JJ
Lancet Haematol; 2015 May; 2(5):e194-203. PubMed ID: 26688094
[TBL] [Abstract][Full Text] [Related]
5. Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis.
Admiraal R; Nierkens S; de Witte MA; Petersen EJ; Fleurke GJ; Verrest L; Belitser SV; Bredius RGM; Raymakers RAP; Knibbe CAJ; Minnema MC; van Kesteren C; Kuball J; Boelens JJ
Lancet Haematol; 2017 Apr; 4(4):e183-e191. PubMed ID: 28330607
[TBL] [Abstract][Full Text] [Related]
6. Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34
Scordo M; Bhatt V; Hilden P; Smith M; Thoren K; Cho C; Shah GL; Maloy MA; Papadopoulos EB; Jakubowski AA; Avecilla ST; O'Reilly RJ; Castro-Malaspina H; Tamari R; Shaffer BC; Boelens JJ; Perales MA; Giralt SA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1526-1535. PubMed ID: 30831208
[TBL] [Abstract][Full Text] [Related]
7. Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation.
van Roessel I; Prockop S; Klein E; Boulad F; Scaradavou A; Spitzer B; Kung A; Curran K; O'Reilly RJ; Kernan NA; Cancio M; Boelens JJ
Cytotherapy; 2020 Sep; 22(9):503-510. PubMed ID: 32622752
[TBL] [Abstract][Full Text] [Related]
8. Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.
Tamari R; Brown S; Devlin SM; Kosuri S; Maloy MA; Ponce DM; Sauter C; Shaffer B; Dahi P; Young JW; Jakubowski A; Papadopoulos EB; Castro-Malaspina H; Perales MA; Giralt SA; Gyurkocza B
Transplant Cell Ther; 2021 Oct; 27(10):852.e1-852.e9. PubMed ID: 34214736
[TBL] [Abstract][Full Text] [Related]
9. Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis.
Troullioud Lucas AG; Lindemans CA; Bhoopalan SV; Dandis R; Prockop SE; Naik S; Keerthi D; de Koning C; Sharma A; Nierkens S; Boelens JJ
Cytotherapy; 2023 Sep; 25(9):977-985. PubMed ID: 37330731
[TBL] [Abstract][Full Text] [Related]
10. Pretransplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Nonrelapse Mortality in Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK; Ostrowski SR; Schierbeck F; Andersen NS; Friis LS; Kornblit B; Petersen SL; Schjødt I; Sengeløv H
Transplant Cell Ther; 2023 Feb; 29(2):97.e1-97.e6. PubMed ID: 36375798
[TBL] [Abstract][Full Text] [Related]
11. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics of Total Rabbit Anti-thymocyte Globulin in Non-obese Adult Patients Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancy.
Takahashi T; Teramoto M; Matsumoto K; Jaber MM; Tamaki H; Ikegame K; Yoshihara S; Kaida K
Clin Pharmacokinet; 2023 Aug; 62(8):1081-1091. PubMed ID: 37284975
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
de Koning C; Prockop S; van Roessel I; Kernan N; Klein E; Langenhorst J; Szanto C; Belderbos M; Bierings M; Boulad F; Bresters D; Cancio M; Curran K; Kollen W; O'Reilly R; Scaradavou A; Spitzer B; Versluijs B; Huitema A; Lindemans C; Nierkens S; Boelens JJ
Blood; 2021 Feb; 137(6):848-855. PubMed ID: 33150379
[TBL] [Abstract][Full Text] [Related]
15. CD34
Barba P; Martino R; Zhou Q; Cho C; Castro-Malaspina H; Devlin S; Esquirol A; Giralt S; Jakubowski AA; Caballero D; Maloy M; Papadopoulos EB; Piñana JL; Fox ML; Márquez-Malaver FJ; Valcárcel D; Solano C; López-Corral L; Sierra J; Perales MA
Biol Blood Marrow Transplant; 2018 May; 24(5):964-972. PubMed ID: 29305194
[TBL] [Abstract][Full Text] [Related]
16. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
[TBL] [Abstract][Full Text] [Related]
17. Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.
Orfali N; Zhang MJ; Allbee-Johnson M; Boelens JJ; Artz AS; Brunstein CG; McNiece IK; Milano F; Abid MB; Chee L; Diaz MA; Grunwald MR; Hematti P; Hsu J; Lazarus HM; Munshi PN; Prestidge T; Ringden O; Rizzieri D; Riches ML; Seo S; Solh M; Solomon S; Szwajcer D; Yared J; van Besien K; Eapen M
Transplant Cell Ther; 2021 Dec; 27(12):993.e1-993.e8. PubMed ID: 34507002
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes.
Langenhorst JB; van Kesteren C; van Maarseveen EM; Dorlo TPC; Nierkens S; Lindemans CA; de Witte MA; van Rhenen A; Raijmakers R; Bierings M; Kuball J; Huitema ADR; Boelens JJ
Blood Adv; 2019 Jul; 3(14):2179-2187. PubMed ID: 31324638
[TBL] [Abstract][Full Text] [Related]
19. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
20. Effects of two doses of anti-T lymphocyte globulin-Fresenius given after full-match sibling stem cell transplantation in acute myeloblastic leukemia patients who underwent myeloablative fludarabine/busulfan conditioning.
Boga C; Yeral M; Gereklioglu C; Asma S; Maytalman E; Aytan P; Kozanoglu I; Sariturk C; Ozdogu H
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):149-157. PubMed ID: 29474820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
